Cosan (CSAN3) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
22 May, 2026Executive summary
Reported a net loss of R$1.6 billion in Q1 2026, an improvement from R$1.8 billion in Q1 2025, mainly due to improved portfolio performance and non-cash impacts from early debt prepayments and related tax effects.
Dividends and interest on capital received totaled R$36 million, down sharply from R$1.5 billion in Q1 2025.
Ceased recognizing Raízen's results as of March 31, 2026, after the investment's carrying value was reduced to zero following impairments and restructuring.
Early prepayment of 2029, 2030, and 2031 bonds led to R$1.0 billion in non-cash impacts, offset by stronger equity income from investees.
Financial highlights
Net loss of R$1.6 billion in Q1 2026, improved year-over-year; consolidated net sales revenue was R$9.0 billion, down 6.6% year-over-year.
Expanded net debt at R$11.5 billion, up 18% sequentially but down 34% year-over-year after a capital increase.
Gross debt reduced by R$6.2 billion through early redemption of debentures and bonds.
Ended the quarter with R$7.7 billion in cash and equivalents.
Outlook and guidance
Focus remains on deleveraging and simplifying the holding company portfolio, with ongoing initiatives to sell stakes in portfolio companies.
No intention to remain a portfolio investment vehicle; plan to distribute shares of subsidiaries to shareholders as leverage is reduced.
Management emphasized a solid capital structure and liquidity, despite Raízen's restructuring and ongoing negotiations with creditors.
Rumo is nearing completion of the first phase of the Mato Grosso rail project, supporting future growth.
Latest events from Cosan
- EBITDA and net income fell, but major asset sales and capital raises improved leverage and liquidity.CSAN3
Q4 20259 Jul 2026 - Net loss reached R$1.8B, EBITDA fell 30%, but net debt dropped to R$17.5B after asset sales.CSAN3
Q1 20258 Jul 2026 - EBITDA rose, net income fell, and management changes and acquisitions shaped the quarter.CSAN3
Q3 20242 Jul 2026 - EBITDA rose 15% to R$7.1bn, net loss narrowed, and capital discipline remained strong.CSAN3
Q2 20242 Jul 2026 - Net revenue rose 11%, but large impairments led to a R$9.4 billion net loss in 2024.CSAN3
Q4 20242 Jul 2026 - EBITDA and net income declined, but R$10.5 billion equity raised improved capital structure.CSAN3
Q3 20253 Feb 2026 - EBITDA fell to R$6.0bn, net loss widened, and leverage rose to 3.4x as segment results diverged.CSAN3
Q2 20253 Feb 2026